Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
The clock is ticking on TikTok. Or is it? And if it is, whose hand is on the alarm setting as of this morning?
The chip giant’s patent history signals its ideas for the future of the data center.
‘We rushed into the cloud. It’s not necessarily the answer.’